MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.
Saved in:
| Title: | MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. |
|---|---|
| Authors: | Zhao H; Dalian Medical University, Dalian, China., Yu X; Dalian Medical University, Dalian, China., Ding Y; Dalian Medical University, Dalian, China., Zhao J; Dalian Medical University, Dalian, China., Wang G; Dalian Medical University, Dalian, China., Wu X; Dalian Medical University, Dalian, China., Jiang J; Obstetrics and Gynecology Hospital, Dalian, China., Peng C; Department of Biology, York University, Toronto, Canada., Guo GZ; Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, USA., Cui S; Dalian Medical University, Dalian, China. |
| Source: | Oncotarget [Oncotarget] 2016 Aug 16; Vol. 7 (33), pp. 53254-53268. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
